Ideas
Sustainability report (Article 29-LEC)
Discover the Land Degradation Neutrality Fund 2023 Impact Report
Investing Insights from the Sustainable Equities Team
Bi-annual market review & outlook
Bi-annual market review & outlook
The growing market for GLP 1 DRUGSAs obesity rates swell worldwide, popular GLP-1 (Glucagon-like peptide-1) drugs such as Ozempic and Wegovy have generated investor interest. Demand for these drugs has outstripped supply and companies such as Novo Nordisk and Eli Lilly have a strong hold on the market share. Investors should also consider the broader market opportunities and cross-sector implications of GLP-1 drugs.
Discover the Sustainable Ocean Fund 2023 Impact Report.
Discover the 2023 impact report of our energy transition infrastructure platform.
